JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation

Sep.11.2025
JUUL Labs Accuses NJOY and Altria of Patent Infringement; U.S. ITC Launches Section 337 Investigation
The U.S. International Trade Commission (USITC) has instituted an investigation titled Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) based on a complaint by JUUL Labs, Inc. JUUL alleges that NJOY, its parent and affiliates at Altria Group, infringed U.S. Patent No. 12,156,533 through the importation and sale of certain ENDS devices, cartridges, and components. JUUL seeks a limited exclusion order and cease-and-desist orders. Respondents must answer within 20 d

Key Points

 

  • Investigation No.: 337-TA-1460; Institution Date: September 9, 2025.
  • Patent & Claims at Issue: U.S. Patent No. 12,156,533, claims 1–8 and 10.
  • Complainant: JUUL Labs, Inc. (Washington, D.C.).
  • Respondents: NJOY, LLC; NJOY Holdings, Inc.; Altria Group, Inc.; Altria Group Distribution Company; Altria Client Services LLC.
  • Accused Products (plain description): Electronic nicotine delivery systems (ENDS) / vaporizer devices, companion cartridges and parts (including cartridge housings, nicotine-salt e-liquids, heating elements/atomizers, chargers, batteries), and subcomponents.
  • Requested Relief: Limited Exclusion Order (LEO) and Cease-and-Desist Orders (C&D).
  • Procedure: A USITC Administrative Law Judge will conduct the hearing; the Office of Unfair Import Investigations (OUII) is not participating as a party.
  • Response Deadline: Respondents must file answers within 20 days of service. Failure to respond to each allegation may result in default and issuance of exclusion and/or cease-and-desist orders.

 


 

2Firsts, September 10, 2025 — The U.S. International Trade Commission (USITC) has issued a Notice of Institution initiating an investigation in Certain Vaporizer Devices, Cartridges Used Therewith, and Components Thereof (II) following a complaint filed by JUUL Labs, Inc. under Section 337 of the Tariff Act.

 

Complainant:

 

JUUL Labs, Inc.

 

 

Respondents:

 

NJOY, LLC

NJOY Holdings, Inc.

Altria Group, Inc.

Altria Group Distribution Company

Altria Client Services LLC

 

 

According to the notice, JUUL’s August 8, 2025 complaint alleges that respondents’ products, in the importation, sale for importation, or post-importation sale within the United States, infringe U.S. Patent No. 12,156,533 (the “‘533 patent”), specifically claims 1–8 and 10.

 

The USITC defines the scope of investigation in plain terms to include ENDS/vaporizer devices, their cartridges, and related components (such as cartridge housings, nicotine-salt e-liquids, heating elements/atomizers, chargers, batteries) as well as subcomponents.

 

JUUL requests that the Commission issue a limited exclusion order barring infringing products from entry into the United States and cease-and-desist orders against named domestic respondents.

 

The Commission’s Chief Administrative Law Judge will assign an ALJ to conduct proceedings. The USITC’s Office of Unfair Import Investigations (OUII) will not participate as a party in this matter.

 

Per the notice, respondents must file an answer within 20 days of service addressing each allegation in the complaint and the notice of investigation. Failure to do so may be deemed a waiver of the right to appear and contest, enabling the ALJ and Commission to make findings of fact and issue initial and final determinations that could result in exclusion and/or cease-and-desist orders.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Warner Robins City Council Pauses New Vape Shop Licensing
Warner Robins City Council Pauses New Vape Shop Licensing
The Warner Robins City Council has unanimously approved a six-month moratorium on issuing new licenses for retail liquor package stores and businesses primarily selling vape, CBD, tobacco, and related products. The pause will remain in effect until June 2, 2026, unless further action is taken, while pending applications are exempt.
Dec.16 by 2FIRSTS.ai
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s MPF and Anvisa sign pact to intensify enforcement against vapes
Brazil’s Federal Public Prosecutor’s Office (MPF) and health regulator Anvisa signed a cooperation protocol to strengthen enforcement against electronic smoking devices (DEFs) and expand health-risk awareness campaigns.
Feb.03 by 2FIRSTS.ai
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
Product | 5ml/2ml Dual Versions, Up to 45W Output: VAPORESSO Launches LUXE X3 on Official Website
VAPORESSO has listed the LUXE X3, a new addition to its LUXE X series, on its official website. The device features a 2,600mAh built-in battery, adjustable 5–45W output and a 0.8-inch digital display, and comes with a 5ml pod (2ml for the TPD version). The LUXE X3 has also appeared on some UK and US online retailers for pre-order, with prices below the company’s stated MSRP of $37.9.
Jan.19 by 2FIRSTS.ai
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
FDA Details Carcinogenicity Tiering and ELCR Framework as Small Manufacturers Press for Predictability
During the “Toxicological Profile” session at FDA’s Feb 10 PMTA roundtable, officials outlined the carcinogenicity tiering system and Excess Lifetime Cancer Risk (ELCR) framework used in ENDS reviews under the APPH standard. Small manufacturers questioned database transparency, exposure assumptions, and the existence of clear compliance benchmarks. FDA reiterated toxicological risk is assessed case by case within a broader population-level determination.
Feb.11
Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
Around 58,000 counterfeit vapes and tobacco seized from UK 's Hampshire streets over the past year
UK's Hampshire Trading Standards says around 58,000 counterfeit vapes and tobacco products have been seized from Hampshire over the last year. Richard Strawson, Hampshire’s Head of Trading Standards, said officers often find vape products disguised under fake branding.
Jan.05 by 2FIRSTS.ai
Philippine FDA Requires Licenses for Vape Products with Medical Claims
Philippine FDA Requires Licenses for Vape Products with Medical Claims
The Philippine Food and Drug Administration has announced that establishments selling vaporized nicotine and non-nicotine products and novel tobacco products with medicinal or therapeutic claims must secure Licenses to Operate. Such products are also required to be registered as pharmaceutical products through the Center for Drug Regulation and Research. The FDA urged stakeholders to comply with the new requirements to ensure product safety, efficacy and quality.
Dec.22 by 2FIRSTS.ai